Vitek IP opens sale of medical simulation patent portfolio

Vitek IP says it is the exclusive representative for a portfolio of three U.S. patents tied to augmented reality, virtual reality and mixed reality medical training. The company plans to review offers as they come in and expects to complete a transaction in Q1 2027.

Why it matters: - The portfolio targets immersive medical training, a market that includes nursing education, surgical simulation and clinician assessment. - The patents could matter to companies building AR, VR and MR healthcare platforms because the claims cover user interaction tracking, procedural simulation and competency evaluation. - Vitek IP says the portfolio is being offered at a time when AR/VR-based medtech tools are expanding across education, skills testing and performance monitoring.

What happened: - Vitek IP, LLC announced that it is the exclusive representative for the sale of the Medical Simulation Intelligence patent portfolio. - CodeScribe originally developed the portfolio for augmented reality clinical simulation technologies. - The announcement was made October 22, 2026, in Portland, Oregon.

The details: - The portfolio includes three U.S. patents covering immersive healthcare education and simulation-based clinical training. - The patents address user interaction tracking, procedural simulation and competency assessment across AR, VR, MR and medical patient simulation environments. - One patent covers movement tracking in medical simulations, including detection and processing of interactions with virtual objects and simulated clinical environments. - That patent supports gesture recognition, hand movements and virtual procedural interactions in hands-on training. - The movement-tracking patent has 12 years of life remaining. - Vitek IP says the central claim is implemented by numerous providers of AR/VR medical training platforms and surgical simulators. - Another patent covers assessment of clinical performance during medical simulation. - That patent captures participant actions, evaluates them against established protocols and determines compliance before producing an assessment. - The assessment patent has 13 years of life remaining. - Vitek IP says several patient simulation systems and AR/VR-based clinical training and assessment platforms use that patent. - Vitek IP has confidential claim charts showing demonstrated use and value of the technology. - The company says interested buyers can request an overview or detailed market materials by contacting info@vitek-ip.com. - The portfolio materials identify Vitek IP’s website as more information. - Vitek IP also lists its LinkedIn page as the company’s social profile.

Between the lines: - The sale packages patents around two core commercialization themes: how trainees interact inside simulations and how systems score their performance. - The remaining patent life suggests the assets may still have usable term for licensing or acquisition strategies. - The reference to existing implementations signals Vitek IP is positioning the portfolio around established market relevance, not just speculative applications.

What's next: - Vitek IP says offers will be reviewed as they are received. - The patent owner intends to finalize a transaction in Q1 2027. - Potential buyers can request portfolio materials from info@vitek-ip.com.

The bottom line: - Vitek IP is marketing a patent set built for the fast-growing market for immersive medical simulation and assessment software.